A Case of Sterile Endophthalmitis after Repeated Intravitreal Bevacizumab Injection
- 1 June 2008
- journal article
- case report
- Published by Mary Ann Liebert Inc in Journal of Ocular Pharmacology and Therapeutics
- Vol. 24 (3), 362-363
- https://doi.org/10.1089/jop.2007.0126
Abstract
Purpose: The aim of this study was to describe a case of sterile endophthalmitis after repeated intravitreal bevacizumab injections for the treatment of choroidal neovascularization secondary to angioid streaks. Methods: This study was done as a case report. Results: A 57-year-old man who received a third injection of intravitreal bevacizumab for the treatment of choroidal neovascularization owing to angioid streaks developed sterile endophthalmitis. The patient's condition improved after hourly topical steroid and antibiotic drops without a sequele. Conclusions: The intravitreal injection of bevacizumab has the potential for the development of sterile endophthalmitis. The patients should be warned against this possible adverse reaction, especially after repeated injections.Keywords
This publication has 6 references indexed in Scilit:
- INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina, 2007
- Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaksActa Ophthalmologica Scandinavica, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- EVALUATION OF ANTERIOR CHAMBER INFLAMMATORY ACTIVITY IN EYES TREATED WITH INTRAVITREAL BEVACIZUMABRetina, 2006
- CASE OF ANTERIOR UVEITIS AFTER INTRAVITREAL INJECTION OF BEVACIZUMABRetina, 2006
- Absence of Histologic Retinal Toxicity of Intravitreal Bevacizumab in a Rabbit ModelAmerican Journal of Ophthalmology, 2006